Investing

Galapagos : GLPG

GLPG

Stock Data

$28.00

$0.17 (0.61%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Galapagos NV is a pioneering biopharmaceutical company based in Mechelen, Belgium, focusing on the discovery, development, and commercialization of innovative medicines for diseases with significant unmet medical needs. Its notable work includes the development of filgotinib, a promising treatment for various inflammatory conditions, and a portfolio of other potential therapies in different stages of clinical trials. Galapagos NV collaborates with leading global pharmaceutical companies like Gilead Sciences, AbbVie, and Novartis to bring groundbreaking treatments to patients worldwide.

All Galapagos Articles

8 Articles

Lee Jackson | Apr 14, 2021 at 8:57 AM EDT

Top Analyst Upgrades and Downgrades: Alphabet, Facebook, Harley-Davidson, JetBlue, Lowe’s, Occidental, Overstock.com, Snap, Southwest Air and More

Wednesday's top analyst upgrades and downgrades included Alphabet, Facebook, Harley-Davidson, JetBlue Airways, Lowe's Companies, Occidental Petroleum, Overstock.com, Snap and Southwest…

Lee Jackson | Feb 23, 2021 at 8:52 AM EST

Top Analyst Upgrades and Downgrades: Advance Auto Parts, Dish Network, Intuit, Kroger, Palo Alto Networks, Starbucks, Texas Instruments and More

Tuesday's top analyst upgrades and downgrades included Advance Auto Parts, Dish Network, Intuit, Kroger, Palo Alto Networks, Qorvo, Starbucks and…

Chris Lange | Dec 16, 2020 at 10:59 AM EST

Why Gilead Retreated on Rheumatoid Arthritis Treatment

Galapagos was crushed on Wednesday after the firm, in conjunction with Gilead, announced a new commercialization and development agreement for…

Jon C. Ogg | Aug 25, 2020 at 9:06 AM EDT

Top Analyst Upgrades and Downgrades: Crocs, Gap, GW Pharma, Lowe’s, Merck, Nio, Palo Alto, Phillips 66, Starbucks, Vital Farms and More

Tuesday's top analyst upgrades and downgrades included Crocs, Gap, GW Pharmaceuticals, Lowe's Companies, Merck, Nio, Palo Alto Networks, Phillips 66,…

Chris Lange | Aug 19, 2020 at 10:25 AM EDT

The FDA Comes Down on Gilead and Galapagos With CRL

The FDA has come down on an investigational treatment for moderately to severely active from Gilead Sciences and Galapagos.

Jon C. Ogg | Feb 24, 2020 at 9:14 AM EST

Top Analyst Upgrades and Downgrades: Agilent, Antero, Chewy, Domino’s, eHealth, First Solar, Kraft Heinz, Newmont, Square, Tilray, Wayfair and More

Monday's top analyst upgrades, downgrades and initiations included Agilent Technologies, Antero Midstream, Chewy, Domino's Pizza, eHealth, First Solar, Kraft Heinz,…

Jon C. Ogg | Feb 20, 2020 at 9:05 AM EST

Top Analyst Upgrades and Downgrades: AMD, AEP, Analog Devices, CenturyLink, Dish, Herbalife, NextEra, NRG, On Semi, SolarEdge and More

Thursday's top analyst upgrades, downgrades and initiations included Advanced Micro Devices, American Electric Power, Analog Devices, CenturyLink, Dish Network, Herbalife,…

Jon C. Ogg | Jan 6, 2020 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: Alphabet, Apple, BofA, Citigroup, Dollar Tree, Nordstrom, Salesforce, Travelers, JD.com and More

Monday's top analyst upgrades, downgrades and initiations included Alphabet, Apple, Bank of America, Citigroup, Dollar Tree, Nordstrom, Salesforce, Travelers and…